Lifshitz & Miller LLP Announces Investigation of Alteryx, Inc., Array BioPharma Inc., Bruker Corporation, Eagle Bancorp, Inc., Omega Healthcare Investors, Inc., Otsuka Holdings Co., Ltd., Tivity Health, Inc. and Triangle Capital Corporation

365
0
SHARE

NEW YORK, Dec. 28, 2017

Alteryx, Inc. (AYX)

Lifshitz & Miller announces an investigation on behalf of AYX investors concerning whether AYX failed to secure a database for 123 million American households.

If you are an AYX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Array BioPharma Inc. (ARRY)

Lifshitz & Miller announces an investigation on behalf of ARRY investors concerning whether ARRY issued false and misleading statements about its Phase 3 study for patients with NRAS-mutant melanoma.

If you are an ARRY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Bruker Corporation (BRKR)

Lifshitz & Miller announces an investigation on behalf of BRKR investors concerning whether BRKR issued false and misleading statements about accounting practices related to revenue recognition.

If you are a BRKR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Eagle Bancorp, Inc. (EGBN)

Lifshitz & Miller announces an investigation on behalf of EGBN investors concerning whether EGBN insiders enriched themselves through undisclosed special deals from customer relationships.

If you are an EGBN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Omega Healthcare Investors, Inc. (OHI)

Lifshitz & Miller announces an investigation on behalf of OHI investors concerning whether OHI failed to disclose that certain of OHI's operators were experiencing worsening liquidity issues.

If you are an OHI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Otsuka Holdings Co., Ltd. (OTSKY)

Lifshitz & Miller announces an investigation on behalf of OTSKY investors concerning whether an OTSKY subsidiary illegally marketed Nuedexta.

If you are an OTSKY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Tivity Health, Inc. (TVTY)

Lifshitz & Miller announces an investigation on behalf of TVTY investors concerning whether TVTY failed to disclose that its customer, United Healthcare, Inc., planned to expand its fitness benefits to seniors, directly competing with TVTY's core program.

If you are a TVTY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Triangle Capital Corporation (TCAP)

Lifshitz & Miller announces an investigation on behalf of TCAP investors concerning whether TCAP issued false and misleading statements about certain of its mezzanine loan deals.

If you are a TCAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/lifshitz–miller-llp-announces-investigation-of-alteryx-inc-array-biopharma-inc-bruker-corporation-eagle-bancorp-inc-omega-healthcare-investors-inc-otsuka-holdings-co-ltd-tivity-health-inc-and-triangle-capital-c-300575917.html

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com

Powered by WPeMatico